Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001415889-25-021836
Filing Date
2025-08-14
Accepted
2025-08-14 16:13:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11157
2 JOINT FILING AGREEMENT ex-99-08142025_080858.htm EX-99.1 3584
  Complete submission text file 0001415889-25-021836.txt   16426
Mailing Address 374 RUE SAINT ST HONORE PARIS I0 75001
Business Address 374 RUE SAINT ST HONORE PARIS I0 75001 33-1-85-73-6603
Andera Partners (Filed by) CIK: 0001757283 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94000 | Film No.: 251219213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)